Last Updated: June 22, 2026

ENALAPRIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Enalapril patents expire, and when can generic versions of Enalapril launch?

Enalapril is a drug marketed by Alkem Labs Ltd, Amneal, Annora Pharma, Aurobindo Pharma, Bionpharma, Aiping Pharm Inc, Apothecon, Aurobindo Pharma Usa, Chartwell Rx, Heritage Pharma, Ivax Sub Teva Pharms, Krka Dd Novo Mesto, Mylan, Prinston Inc, Regcon Holdings, Sandoz Inc, Senores Pharms, Sun Pharm Inds Ltd, Taro, Unique Pharm, Watson Labs, Cosette, Mpp Pharma, Rising, Taro Pharm Inds, Chartwell Injectable, Dr Reddys, Hikma Farmaceutica, and Hospira. and is included in thirty-six NDAs.

The generic ingredient in ENALAPRIL is enalaprilat. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalaprilat profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Enalapril

A generic version of ENALAPRIL was approved as enalaprilat by CHARTWELL INJECTABLE on August 22nd, 2000.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ENALAPRIL?
  • What are the global sales for ENALAPRIL?
  • What is Average Wholesale Price for ENALAPRIL?

US Patents and Regulatory Information for ENALAPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075727-001 Sep 18, 2001 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Prinston Inc ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 213273-004 Jul 7, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Krka Dd Novo Mesto ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075369-001 Aug 22, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma Farmaceutica ENALAPRILAT enalaprilat INJECTABLE;INJECTION 078687-001 Dec 23, 2008 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for ENALAPRIL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.